Editors’ Picks, April 2024: Targeting Metabolism, KRAS, and More
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
April picks include metabolic interventions for acute myeloid leukemia, new inhibitors of KRAS signaling, and more.
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
The AACR Annual Meeting 2023 kicks off Friday, April 14, with thousands of cancer researchers from around the world...
As we welcome spring, enjoy the latest round of editors’ picks selected by the editors of AACR’s 10 journals....
Outside the lab, Frank McCormick, PhD, FAACR, is a racecar driver, nurturing a passion he developed decades ago. (“We...
When teacher Ellen Reich began treatment for multiple myeloma in 2014, a sequence of therapies approved by the U.S....
The 2020 death of actor Chadwick Boseman shocked the public, sparking grief in those who revered his portrayal of...
The immune system is designed to operate like a well-oiled machine. With a myriad of distinct cell types, a...
As February gives way to March, we bring you the latest round of editors’ picks selected by the editors...
In the United States, about 40% of cancer cases are associated with preventable risk factors. According to the AACR...
Two years ago, amid increased awareness of the need to diversify the scientific work force and end cancer health...